Fralick, M., Colacci, M., Odutayo, A., Siemieniuk, R., & Glynn, R
The advent of obesity-indicated drugs like Wegovy, Saxenda, and Zepbound that have demonstrated not just weight loss, but also cardiovascular benefits has led insurance companies and policymakers alike to reconsider this class of drugs for formulary inclusion
**Combats Aging Signs** Reduces wrinkles, fine lines, and sagging for firmer, smoother skin
& Galea, I
How will my plan change as I lose weight
Trends in use over time are complicated by multiple means of acquiring the drug: through administration by physicians in clinics and hospitals and by caregivers using over-the-counter formulations at home